SCHEMBL8459378

SCHEMBL8459378

O=C(O)C(c1ccccc1)C(c1cccc2[nH]ccc12)[PH](=O)O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.41
CYP2D6 P10635 1/20 0.40
MGAM O43451 3/20 0.37
GAA P10253 3/20 0.37
SI P14410 3/20 0.37
MGAM2 Q2M2H8 3/20 0.37
GOT1 P17174 1/20 0.36
MAPK14 Q16539 2/20 0.35
NOD2 Q9HC29 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
MCL1 Q07820 1/20 0.34
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8459366 0.84 MGAM (0.50) CYP2D6MGAMGAASIMGAM2
SCHEMBL7647520 0.77 HDAC1 (0.35) HPGDSGOT1MAPK14MEN1KMT2A
SCHEMBL29966571 0.70 PTGS2 (0.42) MAPTAHR
SCHEMBL6099297 0.70 PTGS2 (0.42) MAPTAHR
SCHEMBL8461236 0.68 CYP2D6 (0.42) CYP2D6GAAMAPT
SCHEMBL10502553 0.68 GPR84 (0.57) CYP2D6MGAMGAASIMGAM2
SCHEMBL7613557 0.68 HPGDS (0.40) HPGDSMGAMGAASIMGAM2
SCHEMBL2300239 0.68 SLC6A4 (0.50) HPGDSCYP2D6MGAMGAASI
SCHEMBL16014125 0.67 MEN1 (0.52) CYP2D6MGAMGAASIMGAM2
SCHEMBL27721184 0.67 CYP2D6 (0.42) HPGDSCYP2D6MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0936914-A4 1999-08-25 EP disclosed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP disclosed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO disclosed